April 07, 2026
Global health discourse continues to invoke the lessons of COVID-19: invest in systems, strengthen preparedness, build resilient public health capacity. Yet in 2026, the financial architecture required to sustain these ambitions appears to be weakening. This World Health Day, an important concern to consider is the steady global shift in cuts to public health financing, rather than an immediate collapse of health systems.
Within a short span, global health financing has plateaued or declined in real terms, even as health needs remain high and in many cases have intensified. The post-COVID-19 pandemic problem is now as much fiscal as it is epidemiological.
Declining Development Assistance and Donor Fatigue
Recent estimates from the OECD (Organisation for Economic Co-operation and Development) suggest that official development assistance (ODA) declined by around 9 percent in 2024, with projections indicating a further drop of 9 to 17 percent in 2025. Bilateral ODA for health was expected to fall by 19 to 33 percent compared with 2023 levels, dropping even below pre-pandemic baselines. This, among several other global statistics, reflects donor fatigue, competing geopolitical priorities, rising debt burdens, and domestic fiscal pressures.
Multilateral institutions are also adjusting to tighter budgets. “Investments in development assistance, including resources for health, are decreasing everywhere,” the World Health Organization (WHO) states in its budget document, and in response to this, it has reduced its 2026 to 2027 program budget by about 22 percent, from US$5.3 billion to US$4.2 billion.
Global initiatives are under strain. Gavi, which works on ensuring access to vaccines for children in the world’s poorest countries, entered its 2026 to 2030 funding cycle short of its target. The Fleming Fund, a British aid program that helped low- and middle-income countries tackle antimicrobial resistance, is being wound down. Funding disruptions linked to USAID (the former principal United States government agency responsible for administering civilian foreign aid and development assistance internationally) and the Global Fund (an international financing organization that supports programs to accelerate the end of AIDS, tuberculosis, and malaria as epidemics) have affected implementation in several countries implementation in several countries.
Impact on Health Systems
These shifts dampen not only the scale of funding but also the continuity of core public health functions. A 2025 WHO assessment found that around 70 percent of country offices reported disruptions to health services after reductions in external assistance. In some settings, countries have begun shifting costs onto households, increasing out-of-pocket spending and risking reversals in financial protection.
The effects are already visible across programs. Global immunization coverage has stabilized but remains fragile. WHO and the United Nations Children’s Fund (UNICEF) reported that over 14 million infants remained zero-dose for vaccines in 2024. Malaria programs are in danger, with the United States historically accounting for over a third of global financing. The Global Fund’s tuberculosis (TB) funding allocation for 2024 to 2026 has been reduced by an estimated US$1.4 billion. HIV (Human Immunodeficiency Virus) programs have also reported disruptions, and international aid cuts are likely to affect the burden of HIV infections and mortality directly.
What This Means for India
For India, the implications of reduced global health funding are indirect but significant. India is less dependent on external health aid than many low-income countries, but it remains part of a global ecosystem of financing, surveillance, supply chains, and technical collaboration. Contractions in global health financing can adversely impact vaccine markets, AMR surveillance, research partnerships, and regional disease control, with spillover effects on domestic outcomes.
India’s own financing trajectory presents a mixed picture. The National Health Policy 2017 set a target of increasing public health expenditure to 2.5 percent of Gross Domestic Product (GDP), yet public spending remains below this level even as total health expenditure is around 3.8 percent of GDP. The recent budget reflects targeted increases in areas such as infrastructure and insurance-linked programs, but these gains coexist with structural gaps. Allocation growth has not consistently translated into effective spending, with delays in fund release and uneven utilization across states limiting impact.
This distinction between allocation and effective spending is important. Outcomes depend not only on budgets but on whether financing is sustained, predictable, and translated into functioning systems such as frontline workers, laboratories, surveillance networks, supply chains, and primary care.
India’s recent gains illustrate both progress and fragility – India reduced the number of children who had not received any vaccines (zero-dose) by over 40 percent between 2023 and 2024 and accelerated the decline in tuberculosis incidence. Yet India still accounts for about 26 percent of the global TB burden, and immunization gains remain uneven across states and socioeconomic backgrounds. These areas require continuous and robust investment.
The Risk of Crisis-Driven Financing
A key concern is that public health financing remains crisis-driven. Investments are mobilized during emergencies but are not consistently institutionalized. As attention shifts, programs revert to fragmented funding, short-term grants, and uncertain renewals. This informs not only disease-specific interventions but also foundational capacities such as data systems, workforce retention, infection prevention, and health promotion.
Three priorities follow to address the risks posed by declining and uncertain public health financing. First, core public health functions such as surveillance, immunization, primary care, laboratories, and data systems must be protected as essential budget lines. Second, global health financing should shift toward predictable and pooled mechanisms, such as multi-year funding commitments and pooled international funds. Third, in India, greater attention is needed not only on allocations but also on the ability of states to utilize funds effectively, absorptive capacity, timely fund release, and sustained investment in primary and preventive care.
World Health Day marks the founding of the WHO, and this year’s theme, “Together for Health. Stand with Science,” highlights the role of evidence and cooperation in advancing public health. The COVID-19 pandemic showed that rapid expansion of capacity is possible when financing aligns with urgency. The current moment will determine whether that capacity can be sustained without crisis.
